Conference Details - Overview

Back to Conferences

CME Accreditation and Credit Designation

Physicians:
Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Physician Assistants:
AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.

T-Cell and B-Cell Non-Hodgkin Lymphoma Revisited: Therapeutic Paradigms and Advances

Hilton San Francisco
San Francisco, CA
Dec 5, 2008

Conference Overview

Summary and Purpose

Send your challenging cases and questions to be addressed by the faculty at this symposium:
E-mail: cases@CancerLearning.com
Fax: (214) 367-3305

Therapeutic options in non-Hodgkin lymphoma (NHL) are rapidly evolving, making therapy decisions more complicated. The T-Cell and B-Cell Non-Hodgkin Lymphoma Revisited: Therapeutic Paradigms and Advances symposium will address the latest developments in therapy for T-cell and B-cell NHL. The symposium will focus on 2 broad NHL categories, T-cell malignancies and the less common B-cell malignancies. Following discussion of the pathophysiology of T-cell NHL, recent therapeutic advances in peripheral T-cell lymphoma will be assessed. Clinical scenarios will illustrate in a practical context the application of available clinical data to the treatment of cutaneous T-cell lymphoma. In the latter part of the program, recent advances in B-cell lymphomas such as central nervous system and gastric MALT lymphomas will be discussed. The live program will be conducted in a host-guest interview-style panel discussion, featuring a 10-minute presentation followed by an interview during which questions submitted by the audience will be discussed.

Target Audience

This educational program is directed toward medical oncologists and hematologists. Nurses, physician assistants, fellows, and pharmacists in oncology who are interested in the treatment of hematologic malignancies are also invited to attend.

Learning Objectives

At the conclusion of this symposium, you should be able to:

  • Discuss the pathophysiology of T-cell lymphomas and its therapeutic implications
  • Assess current treatment options for optimal management of peripheral T-cell lymphoma
  • Explain how to integrate emerging treatment options into the clinical management of patients with cutaneous T-cell lymphoma
  • Describe recent clinical advances in the treatment of gastric MALT lymphoma
  • Appraise recent advances in the management of central nervous system lymphoma

Educational Grants

An educational grant for this activity was provided by:


  1. Allos Therapeutics, Inc.